Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian PLCO Cancer Screening Trial CohortReportar como inadecuado




Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian PLCO Cancer Screening Trial Cohort - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

BMC Cancer

, 9:84

First Online: 17 March 2009Received: 12 June 2008Accepted: 17 March 2009DOI: 10.1186-1471-2407-9-84

Cite this article as: Lacey, J.V., Kreimer, A.R., Buys, S.S. et al. BMC Cancer 2009 9: 84. doi:10.1186-1471-2407-9-84

Abstract

BackgroundMultidisciplinary attempts to understand the etiology of breast cancer are expanding to increasingly include new potential markers of disease risk. Those efforts may have maximal scientific and practical influence if new findings are placed in context of the well-understood lifestyle and reproductive risk factors or existing risk prediction models for breast cancer. We therefore evaluated known risk factors for breast cancer in a cancer screening trial that does not have breast cancer as a study endpoint but is large enough to provide numerous analytic opportunities for breast cancer.

MethodsWe evaluated risk factors for breast cancer N = 2085 among 70,575 women who were randomized in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Using Poisson regression, we calculated adjusted relative risks RRs, with 95% confidence intervals CIs for lifestyle and reproductive factors during an average of 5 years of follow-up from date of randomization.

ResultsAs expected, increasing age, nulliparity, positive family history of breast cancer, and use of menopausal hormone therapy were positively associated with breast cancer. Later age at menarche 16 years or older vs. < 12: RR = 0.81, 95% CI, 0.65–1.02 or menopause 55 years or older vs. < 45: RR = 1.29, 95% CI, 1.03–1.62 were less strongly associated with breast cancer than was expected. There were weak positive associations between taller height and heavier weight, and only severe obesity body mass index BMI; kg-m 35 or more vs. 18.5–24.9: RR = 1.21, 95% CI, 1.02–1.43 was statistically significantly associated with breast cancer.

ConclusionThe ongoing PLCO trial offers continued opportunities for new breast cancer investigations, but these analyses suggest that the associations between breast cancer and age at menarche, age at menopause, and obesity might be changing as the underlying demographics of these factors change.

Clinical Trials Registrationhttp:-www.clinicaltrials.gov, NCT00002540.

Download fulltext PDF



Autor: James V LaceyJr - Aimee R Kreimer - Saundra S Buys - Pamela M Marcus - Shih-Chen Chang - Michael F Leitzmann - Robert 

Fuente: https://link.springer.com/



DESCARGAR PDF




Documentos relacionados